Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans.
Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected …

Background Emergence of variants with specific mutations in key epitopes in the spike
protein of SARS-CoV-2 raises concerns pertinent to mass vaccination campaigns and use of …

To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …

Coronavirus disease 2019 (COVID-19) can cause deadly healthcare-associated outbreaks.
In a major London teaching hospital, 66 of 435 (15%) COVID-19 inpatient cases between 2 …

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show
protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral …

This clinical review has been developed for The BMJ in collaboration with BMJ Best Practice,
based on a regularly updated web/mobile topic that supports evidence-based decision …

Objectives: Human papillomavirus (HPV), one of the commonest sexually transmitted
infections, may be a cofactor in HIV acquisition. We systematically reviewed the evidence for an …

Background The scale of the 2022 global mpox (formerly known as monkeypox) outbreak
has been unprecedented. In less than 6 months, non-endemic countries have reported more …

Background Neuropsychiatric presentations of monkeypox (MPX) infection have not been
well characterised, despite evidence of nervous system involvement associated with the …